⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2025Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Retraction: MicroRNA-221-3p Plays an Oncogenic Role in Gastric Carcinoma by Inhibiting PTEN Expression

Oncology Research Editorial Offfce

View at Publisher

Ask AI

Bookmark

Share

Key Points

The retraction of research emphasizes concerns about the role of microRNA-221-3p in gastric carcinoma.
Concerns focus on how microRNA-221-3p inhibits PTEN expression, impacting tumor growth.
The methodology used in the original study has raised significant questions regarding its validity.
This retraction calls for careful scrutiny of similar studies in cancer research.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Retraction highlights how microRNA-221-3p inhibits PTEN expression in gastric carcinoma, suggesting significant implications for cancer research.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Oncology Research Editorial Offfce (2025) studied this question.

synapsesocial.com/papers/68c182399b7b07f3a060e509 https://doi.org/10.32604/or.2025.071885

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1[Retracted] Regulation of miR‑155 affects the invasion and migration of gastric carcinoma cells by modulating the STAT3 signaling pathway2025
2Retraction: MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1.2025
3Retraction Note: MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3.2024 · 1 citations
4Retracted: MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2)2024
5[Retracted] Inhibition of EMMPRIN by microRNA‑124 suppresses the growth, invasion and tumorigenicity of gliomas2025

Retraction Note: Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer2025
RETRACTION: miR-107 Regulates Growth and Metastasis of Gastric Cancer Cells via Activation of the PI3K-AKT Signaling Pathway by Down-Regulating FAT4.2026
Retraction: UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a2025
Hexokinases and Glial Tumor Metabolism: A Bridge between Bioenergetics and Translational OncologyOncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2026
Ovarian Cancer Stem Cells: Mechanisms of Progression and Therapeutic StrategiesOncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2026

More from Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics